Sage Journals: Discover world-class research

Open access

Research article

First published 2026-4

Correlation of E-cadherin,vimentin,CD206,programmed cell death receptor 1,and programmed cell death ligand 1 expressions with clinicopathological factors and prognosis in oral squamous cell carcinoma

Zheng-Yi Lai, Jie Ma, Jia-Yi Yin [...]

Journal of International Medical Research

Retricted access

Case report

First published 2019-1

Nivolumab-induced aplastic anemia: A case report and literature review

Rachel R Comito, Lynette A Badu, Nicholas Forcello

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2022-06

Tislelizumab: A Modified Anti-tumor Programmed Death Receptor 1 Antibody

Lin Zhang, Zhihua Geng, Bo Hao [...]

Cancer Control

Open access

Case report

First published 2022

Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios

Komal Akhtar, Metlapalli Venkata Sravanthi, Josephine D’Angelo [...]

Journal of Investigative Medicine High Impact Case Reports

Open access

Case report

First published 2023-9

Relapse of lupus nephritis induced by nivolumab in an 84-year-old patient with oral cancer: a case report

Zhou Zhou, Qiankun Zhang, Xinbin Wang

Journal of International Medical Research

Retricted access

Research article

First published 2023-1

Effectiveness and safety of pembrolizumab monotherapy in patients with locally advanced or metastatic non-small-cell lung cancer

Rocio Tamayo-Bermejo, Juan Carlos del Rio-Valencia, Beatriz Mora-Rodriguez [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2025

Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)

Hiroki Osumi, Takeru Wakatsuki, Akira Ooki [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2024-04-29

PD-1/PD-L1 pathway: Current research in breast cancer

Salman Ardi Syamsu, Muhammad Faruk, Nilam Smaradania [...]

Breast Disease

Open access

Research article

First published 2023

Rationale and design of phase II clinical trial of dual inhibition with ramucirumab and erlotinib in EGFR exon 19 deletion-positive treatment-naïve non-small cell lung cancer with high PD-L1 expression (SPIRAL-3D study)

Hayato Kawachi, Tadaaki Yamada, Akihiro Yoshimura [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2020-07-02

Biomarkers Towards New Era of Therapeutics for Metastatic Renal Cell Carcinoma

Ryuichi Mizuno, Mototsugu Oya

Kidney Cancer

Search results